Related Experiment Video
Updated: Mar 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings
Mark W Tenforde1, Rae Wake2, Tshepo Leeme3
1Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA USA ; University of Washington Medical Center, 1959 NE Pacific Street, Health Sciences Division #356423, Seattle, WA 98195 USA.
Cryptococcal meningitis significantly impacts HIV patients globally, with higher mortality in low-income nations. This study examines factors contributing to this disparity and proposes immediate, low-cost interventions for improved outcomes.
Area of Science:
- Infectious Diseases
- Global Health
- HIV/AIDS Research
Background:
- Cryptococcal meningitis is a leading cause of death in individuals with HIV/AIDS globally.
- Mortality rates are disproportionately high in low-income countries, exceeding 50% within 10 weeks of diagnosis.
- Significant disparities in treatment outcomes exist between developed and resource-limited settings.
Approach:
- Analyzing factors across the HIV care continuum contributing to outcome gaps.
- Identifying and describing immediate, low-cost, and effective interventions for resource-limited settings.
- Exploring health-system challenges, disease prevention strategies, and novel short-course treatment regimens.
Key Points:
- Numerous factors, including those within the HIV care continuum, explain the treatment outcome gap.
- Low-cost, highly effective measures can be implemented to improve outcomes in resource-limited settings.
- Addressing health-system challenges is crucial for further mortality reduction.
Conclusions:
- Immediate implementation of cost-effective measures can improve cryptococcal meningitis outcomes in resource-limited settings.
- Advancements in disease prevention and novel short-course treatments hold promise for reducing mortality.
- Bridging the gap in outcomes requires a multi-faceted approach addressing care, health systems, and treatment accessibility.
More Related Videos
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Retrovirus Life Cycles
Cytomegalovirus Disease